State Street Corp Cytokinetics Inc Transaction History
State Street Corp
- $2.25 Trillion
- Q2 2024
A detailed history of State Street Corp transactions in Cytokinetics Inc stock. As of the latest transaction made, State Street Corp holds 6,548,536 shares of CYTK stock, worth $345 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
6,548,536
Previous 4,520,358
44.87%
Holding current value
$345 Million
Previous $317 Million
11.95%
% of portfolio
0.02%
Previous 0.01%
Shares
18 transactions
Others Institutions Holding CYTK
# of Institutions
406Shares Held
126MCall Options Held
3.29MPut Options Held
2.01M-
Black Rock Inc. New York, NY14.7MShares$772 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.4MShares$602 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.14MShares$428 Million0.28% of portfolio
-
Wellington Management Group LLP Boston, MA7.51MShares$395 Million0.07% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y94.58MShares$241 Million29.98% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.96B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...